Yahoo Αναζήτηση Διαδυκτίου

Αποτελέσματα Αναζήτησης

1. www.mayoclinic.org › diseases-conditions › asthmaAsthma medications: Know your options - Mayo Clinic

   www.mayoclinic.org › diseases-conditions › asthma

   • Αποθηκευμένο αντίγραφο

   2 Ιουλ 2024 · These asthma medications — sometimes called short-acting beta agonists (SABA) — open the lungs by relaxing airway muscles. Often called rescue medications, they can ease worsening symptoms or stop an asthma attack in progress.

2. www.drugs.com › condition › asthmaList of 57 Asthma Medications Compared - Drugs.com

   www.drugs.com › condition › asthma

   • Αποθηκευμένο αντίγραφο

   Compare risks and benefits of common medications used for Asthma. Find the most popular drugs, view ratings and user reviews.

3. www.ncbi.nlm.nih.gov › books › NBK531455Asthma Medications - StatPearls - NCBI Bookshelf

   www.ncbi.nlm.nih.gov › books › NBK531455

   20 Ιουν 2023 · Several classifications of medications are utilized to treat and manage chronic asthma to improve symptoms and reduce exacerbations. This activity reviews the considerations for the use of asthma medications and discusses the role of the interprofessional team in educating patients on when they are necessary.

4. www.nejm.org › doi › pdfBiologic Therapies for Severe Asthma - The New England Journal of...

   www.nejm.org › doi › pdf

   Biologic agents are efficacious add-on therapies for uncontrolled, severe eosinophilic asthma. These therapies represent major breakthroughs, significantly decreasing exacerbation rates and ...

5. www.ncbi.nlm.nih.gov › books › NBK513535The Role of Immunotherapy in the Treatment of Asthma

   www.ncbi.nlm.nih.gov › books › NBK513535

   SLIT improves asthma symptoms (high SOE); decreases use of long-term control medication and improves FEV 1 (moderate SOE). SLIT may decrease quick-relief medication use, and may improve quality of life (low SOE).

6. breathe.ersjournals.com › content › 17/4/210144A pragmatic guide to choosing biologic therapies in severe asthma

   breathe.ersjournals.com › content › 17/4/210144

   • Αποθηκευμένο αντίγραφο

   Omalizumab is an anti-IgE mAb and is licensed in severe allergic asthma. Current evidence suggests it may decrease exacerbations by augmenting deficient antiviral immune responses in asthma. Like all other biologics, clinical efficacy is greatest in those with elevated T2 biomarkers.

7. my.clevelandclinic.org › health › treatmentsBiologic Therapy for Severe Asthma - Cleveland Clinic

   my.clevelandclinic.org › health › treatments

   • Αποθηκευμένο αντίγραφο

   5 Αυγ 2024 · Biologic therapy for asthma targets different parts of your immune system to help people who have moderate to severe asthma that inhalers and other medicines can’t manage. Side effects may include headache, joint and back pain and a reaction around the injection site.